News
Outlook Therapeutics, Inc. (Nasdaq: OTLK), today announced the Scottish Medicines Consortium (SMC) approval of LYTENAVA™ (bevacizumab gamma) for the treatment of wet age-related macular degeneration ...
Medindia on MSN12h
Diabetes Drug Semaglutide Linked to Vision Loss RiskGLP-1 RA use was linked to a 2.21-fold risk of developing neovascular age-related macular degeneration// (nAMD) * Only 0.2% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback